Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0ACS Omega

Binding and Blocking of Influenza A WT and S31N M2 by Cage Alkyl Amine-Containing Inhibitors

  • Marianna Stampolaki1,2
  • Kumar Tekwani Movellan1,3
  • Kyriakos Georgiou2
  • Abel Cherian Varkey1
  • Andreea L. Turcu4,5
  • Santiago Vázquez4,5
  • Stefan Becker1
  • Antonios Kolocouris2
  • Loren B. Andreas1
5 affiliations
  1. 1Max Planck Institute for Multidisciplinary Sciences , , Am Fassberg 11 , ,
  2. 2National and Kapodistrian University of Athens , , Panepistimiopolis-Zografou , ,
  3. 3University of Delaware , , , ,
  4. 4Universitat de Barcelona , , ,
  5. 5Institute of Biomedicine of the University of Barcelona, IBUB , ,
Open at sourcePDFDOICite

Abstract

Proton conductance of the wild-type (WT) M2 protein of influenza A is inhibited by cage alkyl amines, which bind in the pore of the channel. Conjugates with a methylene-linked aryl group have been shown to block the channel of the prevalent S31N strain with a different mechanism, but at the same binding site. Here, we investigated the binding and blocking of WT and S31N M2 by a set of these amines using different biophysical methods. The binding behavior of the ligands was explored using magic angle spinning NMR. NMR clearly detected binding for WT but not S31N. Correlation of binding data with ligand cage size suggested a significant structural barrier. Using a liposomal proton flux assay, we confirmed that the compounds identified as binders by NMR also blocked the channel. To assess the binding mode of these small molecules, molecular dynamics simulations were performed. The simulations predicted different binding modes to WT or S31N. No binding to the S31N variant was detected by NMR, nor was the channel effectively blocked in the liposomal proton flux assay or MD simulations. A comparison of M218–60 with ectodomain-truncated M2 (M221–97) suggests that a substantial structural barrier limits entry of bulky cage amines and that the structural barrier is influenced by the presence or absence of cytoplasmic residues.

Related

  1. A Cell-Based ELISA for High-Throughput Screening of Inhibitors Blocking Influenza Virus Attachment to the Subtype-Independent α2,6-Sialic Acid Receptor
    Keyu Guo, Jingshuai Wu, Yaru Liu +11
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  2. Novel inhibitors against Cryptosporidium parvum through blocking its energy metabolism
    Chang Xu, Yaru Ji, Qiang Sha +1
    PLOS Neglected Tropical DiseasesPeer-reviewedCC BYFull textEnzymology & metabolismImmunologyPLOSEurope PMC
  3. Opposing cell-type preferences for binding and replication shape influenza A virus infection in human airways
    Josephine von Kempis, Marie O. Pohl, Elisabeth Gaggioli +5
    Science AdvancesPeer-reviewedCC BYFull textEpidemiology & public healthCrossrefEurope PMC
  4. Antibodies targeting a conserved cryptic epitope at the influenza hemagglutinin head-stem interface via distinct binding modes
    G. L. Stroh, H. Lv, C. Chen +7
    bioRxivPreprintCC BYFull textEpidemiology & public healthbioRxiv
  5. Repositioning antiviral phytoconstituents as broad-spectrum inhibitors of influenza A neuraminidase and human metapneumovirus fusion protein
    Nouh Mounadi, Hassan Nour, M’hammed El Kouali +2
    PLOS OnePeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPLOS

Cite

BibTeXRIS
BibTeX
@article{stampolaki2026binding,
  title = {{Binding and Blocking of Influenza A WT and S31N M2 by Cage Alkyl Amine-Containing Inhibitors}},
  author = {Marianna Stampolaki and Kumar Tekwani Movellan and Kyriakos Georgiou and Abel Cherian Varkey and Andreea L. Turcu and Santiago Vázquez and Stefan Becker and Antonios Kolocouris and Loren B. Andreas},
  journal = {ACS Omega},
  year = {2026},
  month = oct,
  doi = {10.1021/acsomega.6c06359},
  url = {https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c06359/5457545/Binding-and-Blocking-of-Influenza-A-WT-and-S31N-M2},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Binding and Blocking of Influenza A WT and S31N M2 by Cage Alkyl Amine-Containing Inhibitors
AU  - Marianna Stampolaki
AU  - Kumar Tekwani Movellan
AU  - Kyriakos Georgiou
AU  - Abel Cherian Varkey
AU  - Andreea L. Turcu
AU  - Santiago Vázquez
AU  - Stefan Becker
AU  - Antonios Kolocouris
AU  - Loren B. Andreas
PY  - 2026
DA  - 2026/10/23
JO  - ACS Omega
DO  - 10.1021/acsomega.6c06359
UR  - https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c06359/5457545/Binding-and-Blocking-of-Influenza-A-WT-and-S31N-M2
AB  - Proton conductance of the wild-type (WT) M2 protein of influenza A is inhibited by cage alkyl amines, which bind in the pore of the channel. Conjugates with a methylene-linked aryl group have been shown to block the channel of the prevalent S31N strain with a different mechanism, but at the same binding site. Here, we investigated the binding and blocking of WT and S31N M2 by a set of these amines using different biophysical methods. The binding behavior of the ligands was explored using magic angle spinning NMR. NMR clearly detected binding for WT but not S31N. Correlation of binding data with ligand cage size suggested a significant structural barrier. Using a liposomal proton flux assay, we confirmed that the compounds identified as binders by NMR also blocked the channel. To assess the binding mode of these small molecules, molecular dynamics simulations were performed. The simulations predicted different binding modes to WT or S31N. No binding to the S31N variant was detected by NMR, nor was the channel effectively blocked in the liposomal proton flux assay or MD simulations. A comparison of M218–60 with ectodomain-truncated M2 (M221–97) suggests that a substantial structural barrier limits entry of bulky cage amines and that the structural barrier is influenced by the presence or absence of cytoplasmic residues.
SN  - 2470-1343
ER  -